<DOC>
	<DOCNO>NCT01835535</DOCNO>
	<brief_summary>The TIVUS II prospective , multicenter , non-randomized , open-label clinical study safety performance TIVUS™ System consist three ( 3 ) concurrent cohort : - TIVUS™ Severe Resistant HTN Cohort - TIVUS™ Moderate Resistant HTN Cohort - TIVUS™ Failed RF Therapy Cohort</brief_summary>
	<brief_title>Continued Safety Performance TIVUS System</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Coronary Vasospasm</mesh_term>
	<criteria>Patient ≥ 18 ≤ 80 year age For Cohort A : Documented office systolic blood pressure &gt; 160 mmHg ( &gt; 150 mmHg diabetic patient ) ; For Cohort B : Documented office systolic blood pressure &gt; 140 mmHg ( &gt; 130 mmHg diabetic patient ) ; For Cohort C : Documented office systolic blood pressure &gt; 150 mmHg ( &gt; 140 mmHg diabetic patient ) Documented 24 hour systolic ABPM &gt; 135 mmHg Adherence stable drug regimen For patient Cohort C : Documented renal denervation procedure RF technology 12 month prior screen Suitable renal artery anatomy Male nonpregnant / nonlactating female Patient understand nature procedure provide write informed consent Patient willing able comply specify study requirement followup evaluation eGFR &lt; 45mL/min/1.73m2 Documented primary pulmonary hypertension Patient experience &gt; 1 episode orthostatic hypotension couple syncope Documented indicator secondary renal hypertension History myocardial infarction , unstable angina pectoris , cerebrovascular accident within 6 month Planned major surgery cardiovascular intervention next 6 month Surgery cardiovascular intervention previous 3 month Hemodynamically significant valvular heart disease Severe debilitate lung disease Patient anticoagulant therapy temporarily withhold perform catheterization Patient single function kidney Documented thrombocytopenia , clot disorder aortic aneurysm Moribund patient , patient comorbidities limit life expectancy le one year Contraindication recommend study medication intravascular contrast material adequately control premedication Concurrent enrollment another trial Main renal artery &lt; 4 mm lumen diameter &lt; 20 mm length Aortorenal angle prevents safe cannulation renal artery Severe common femoral artery , common and/or external iliac artery , renal , iliac aortic calcification tortuosity may compromise safe performance completion procedure Hemodynamically anatomically significant renal artery abnormality stenosis either renal artery Any renal artery stenosis &gt; 50 % visual assessment Any renal artery aneurysm either renal artery A history prior renal artery balloon angioplasty stenting ( patient Cohort A B , also history prior renal denervation time )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>